Drugs Made In America Acquisition Corp. Balance Sheet
Drugs Made In America Acquisition Corp.'s total assets for Q4 2025 were $239.92M, an increase of 0.96% from the previous quarter. DMAA total liabilities were $7.28M for the fiscal quarter, a -1.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.